Delivery Order SPE2DR25D3501-SPE2DR26FL9JM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This contract, valued at $9,013.99, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the pharmaceutical distributor. The order is scheduled for completion by November 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $55,533.83. This firm fixed-price delivery order, which is expected to be completed by November 26, 2025, represents a non-competitive set-aside procurement supporting federal pharmaceutical supply needs. The contract is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $7,176.95. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract and is scheduled for completion by December 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,265.11 on November 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a contract value of $5,425.98 and a completion date of September 3, 2025. This delivery order represents a firm fixed-price, non-set-aside award made through open competition, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The place of performance is located...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package, with a ceiling value of $5,192.09 and a firm fixed price structure. The delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $11,024.17. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract value of $8,956.68. The award represents a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and was executed without set-aside designation, indicating competitive selection. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This competitive, firm fixed-price delivery order carries a ceiling value of $65,798.48 and is scheduled for completion by June 3, 2025. The contract involves no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems. The place of...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9JMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $7,463.62. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of November 26, 2025. This delivery order is issued under AmerisourceBergen's larger pharmaceutical prime vendor contract (SPE2DX) valued at $999,999,999, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a broad range of medications, vaccines, and medical supplies to support Defense Health Agency requirements and other government healthcare systems. The Jardiance delivery exemplifies the company's role in supplying specialty medications, including diabetes treatments, across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 11/24/25 |